Page 81 - Educacional Ponenecias Congreso SEHH-STH 2020

identifies a subset of patients with an increased risk of progression to blast
phase. Ann Diagn Pathol. 2019;40:45-8.
7. Tefferi A, Lasho TL, Guglielmelli P, Finke CM, Rotunno G, Elala Y, et al.Targeted
deep sequencing in polycythemia vera and essential thrombocythemia.
Blood Adv. 2016;1:21-30.
8. Yogarajah M, Tefferi A. Leukemic transformation in myeloproliferative neo-
plasms: a literature review on risk, characteristics and outcome. Mayo Clin
Proc. 2017;92:1118-28.
9. Hidalgo-López JE, Carballo-Zárate A, Verstovsek S, Wang SA, Hu S, Li S, et al.
Bone marrow findings in blast phase of polycythemia vera. Ann Hematol.
2018;97:425-34.
10. Tefferi A, Guglielmell P, Lasho TL, Coltro G, Kinke CM, Loscocco GG, et al.
Mutation-enhanced international prognostic systems for essential thrombo- cythaemia and polycythaemia vera. Br J Haematol. 2020;189(2):291-302.
11. Wang SA, Galili N, Cerny J, Sechman E, Chen SS, Loew J, et al. Chronic myelo- monocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease. Am J Clin Pathol. 2006;126(5):789-97.
12. Boiocchi L, Espinal-Witter R, Geyer JT. Development of monocytosis in pa- tients with primary myelofibrosis indicates an accelerated phase of the dis- ease. Mod Pathol. 2013;26:204-12.
13. Holcombe RF, Treseler PA, Rosenthal DS. Chronic myelomonocytic leukemia transformation in polycythemia vera. Leukemia. 1991;5:606-10.
14. Andrei M, Pandey A, Avezbakiyev B, Wang JC. Chronic myelomonocytic leukemia as a transformation from polycythemia vera, Leuk Res Rep. 2019;11:14-6.
15. Barraco D, Cerquozzi S, Gangat N, Patnaik MM, Lasho T, Finke C, et al. Monocy- tosis in polycythemia vera: clinical and molecular correlates. Am J Hematol. 2017;92:640-5.
LXII Congreso Nacional de la Sociedad Española de Hematología y Hemoterapia / Ponencias
81